180 related articles for article (PubMed ID: 2099845)
21. [Immunology: new approaches to immuno-modulation and immunotherapy].
Kabelitz D
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
[No Abstract] [Full Text] [Related]
22. Unique human tumor antigens: immunobiology and use in clinical trials.
Parmiani G; De Filippo A; Novellino L; Castelli C
J Immunol; 2007 Feb; 178(4):1975-9. PubMed ID: 17277099
[TBL] [Abstract][Full Text] [Related]
23. Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?
Kremer L; Garcia-Sanz JA
Front Immunol; 2018; 9():442. PubMed ID: 29556241
[No Abstract] [Full Text] [Related]
24. Prostate cancer vaccines: current status.
Hwang LC; Fein S; Levitsky H; Nelson WG
Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
[TBL] [Abstract][Full Text] [Related]
25. Prospects for adoptive T cell therapy.
Yee C; Riddell SR; Greenberg PD
Curr Opin Immunol; 1997 Oct; 9(5):702-8. PubMed ID: 9368780
[TBL] [Abstract][Full Text] [Related]
26. Tumor antigen targets and tumor immunotherapy.
Mufson RA
Front Biosci; 2006 Jan; 11():337-43. PubMed ID: 16146735
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy for infection and malignancy in children with cancer.
Frost JD; Sondel PM
Adv Pediatr; 1994; 41():385-413. PubMed ID: 7992692
[No Abstract] [Full Text] [Related]
28. Tumor-associated antigens and biomarkers in cancer and immune therapy.
Malyankar UM
Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
[TBL] [Abstract][Full Text] [Related]
29. Genetically engineered tumor vaccines.
Pardoll DM
Ann N Y Acad Sci; 1993 Aug; 690():301-10. PubMed ID: 7690216
[No Abstract] [Full Text] [Related]
30. [Advances in immunotherapy for pediatric cancer].
Xu X; Zhao H; Tang Y
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):231-4. PubMed ID: 24824398
[No Abstract] [Full Text] [Related]
31. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
32. Tumor immunology: the first century.
Old LJ
Curr Opin Immunol; 1992 Oct; 4(5):603-7. PubMed ID: 1418726
[No Abstract] [Full Text] [Related]
33. Vaccines in lymphoma.
Levy R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
[No Abstract] [Full Text] [Related]
34. [Current status of immunotherapy in oncology].
Zielinski C
Acta Med Austriaca; 1991; 18(1):20-4. PubMed ID: 1713730
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies for imaging and therapy.
Epenetos AA; Kosmas C
Br J Cancer; 1989 Feb; 59(2):152-5. PubMed ID: 2649128
[No Abstract] [Full Text] [Related]
36. Third international Dresden symposium on immunotherapy of cancer.
Schmitz M; Bornhauser M; Ockert D; Rieber EP
Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317
[No Abstract] [Full Text] [Related]
37. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
Zhang T; Herlyn D
Cancer Immunol Immunother; 2009 Apr; 58(4):475-92. PubMed ID: 18925393
[TBL] [Abstract][Full Text] [Related]
38. Personalized cancer vaccines.
Jain KK
Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
[TBL] [Abstract][Full Text] [Related]
39. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
40. [Mix-up of Fc receptors in the response to monoclonal antibodies].
Teillaud JL
Med Sci (Paris); 2012 Jan; 28(1):11-3. PubMed ID: 22289817
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
